Publications by authors named "Naohiko Tanabe"

Claim this Profile
A
Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration.
Taiyo Shijo, Yoichi Sakurada, Yoshiko Fukuda, Seigo Yoneyama, Atsushi Sugiyama, Naohiko Tanabe

Int Ophthalmol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy.
Yoshiko Fukuda, Yoichi Sakurada, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Naohiko Tanabe

J Clin Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Seigo Yoneyama, Yoichi Sakurada, Wataru Kikushima, Atsushi Sugiyama, Mio Matsubara, Naohiko Tanabe

Sci Rep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case.
Yoichi Sakurada, Atsushi Sugiyama, Wataru Kikushima, Seigo Yoneyama, Naohiko Tanabe

Jpn J Ophthalmol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration.
Yoshiko Fukuda, Yoichi Sakurada, Seigo Yoneyama, Wataru Kikushima, Atsushi Sugiyama, Naohiko Tanabe

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AREDS simplified severity scale as a predictive factor for response to aflibercept therapy for typical neovascular age-related macular degeneration.
Yoichi Sakurada, Wataru Kikushima, Atsushi Sugiyama, Seigo Yoneyama, Naohiko Tanabe

Graefes Arch Clin Exp Ophthalmol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
Wataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, Seigo Yoneyama, Naohiko Tanabe

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Predictive of Visual Outcome 1 Year After Intravitreal Aflibercept Injection for Typical Neovascular Age-Related Macular Degeneration.
Wataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, Naohiko Tanabe, Atsuki Kume

J Ocul Pharmacol Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
Yoichi Sakurada, Atsushi Sugiyama, Naohiko Tanabe, Wataru Kikushima, Atsuki Kume

Retina· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degeneration.
Taiyo Shijo, Yoichi Sakurada, Seigo Yoneyama, Atsushi Sugiyama, Wataru Kikushima, Naohiko Tanabe

Graefes Arch Clin Exp Ophthalmol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration.
Wataru Kikushima, Yoichi Sakurada, Seigo Yoneyama, Atsushi Sugiyama, Naohiko Tanabe

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy.
Wataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, Naohiko Tanabe, Atsuki Kume

Graefes Arch Clin Exp Ophthalmol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment of polypoidal choroidal vasculopathy after photodynamic therapy combined with intravitreal ranibizumab.
Wataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, Naohiko Tanabe, Seigo Yoneyama

Jpn J Ophthalmol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Seigo Yoneyama, Yoichi Sakurada, Wataru Kikushima, Atsushi Sugiyama, Naohiko Tanabe

Retina· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration.
Yoichi Sakurada, Seigo Yoneyama, Atsushi Sugiyama, Naohiko Tanabe, Wataru Kikushima

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Second Eye Involvement in Eyes with Unilateral Polypoidal Choroidal Vasculopathy.
Yasushi Tateno, Yoichi Sakurada, Seigo Yoneyama, Wataru Kikushima, Fumihiko Mabuchi, Naohiko Tanabe

Ophthalmic Genet· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a remote operating slit-lamp microscope system with a conventional slit-lamp microscope system for examination of trabeculectomy eyes.
Kenji Kashiwagi, Naohiko Tanabe, Kentaro Go, Mitsuhiro Imasawa, Fumihiko Mabuchi

J Glaucoma· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy.
Yoichi Sakurada, Takeo Kubota, Mitsuhiro Imasawa, Fumihiko Mabuchi, Yasushi Tateno, Naohiko Tanabe

Ophthalmology· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy.
Yoichi Sakurada, Takeo Kubota, Mitsuhiro Imasawa, Fumihiko Mabuchi, Naohiko Tanabe

Retina· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy.
Yoichi Sakurada, Takeo Kubota, Mitsuhiro Imasawa, Toyoaki Tsumura, Fumihiko Mabuchi, Naohiko Tanabe

Retina· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy.
Yoichi Sakurada, Takeo Kubota, Fumihiko Mabuchi, Mitsuhiro Imasawa, Naohiko Tanabe

Am J Ophthalmol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis